Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Brian, If you are reading this board

Whats the benefit in that? - If we're too far away, shareholders will exit. If that happens, S&L's conversion process slows down, extending further. Every advantage being engineered to keep the price up, goes away.

Help me out on this one, where's the advantage for us?

Regards 

 

 

Share
New Message
Please login to post a reply